Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Growing Geriatric Population and The Raising Cases of Diabetics
4.1.1.2. Market Developments
4.1.2. Restraints
4.1.2.1. High Cost
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Wound Dressings
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.2.3. Hydrogel Dressings
7.2.4. Foam Dressings
7.2.5. Silicone Dressings
7.2.5.1. Silicone Lite Foam Dressing
7.2.5.2. Silicone absorbent dressings
7.2.5.3. Silicone gel sheets
7.2.6. Hydrocolloids Dressings
7.2.7. Alginate Dressings
7.2.8. Super Absorbent Dressings
7.2.9. Silver Wound Dressing
7.2.10. Collagen Dressing
7.2.11. Non-Silver Dressing
7.2.12. Hemostatic Dressing
7.2.13. Nanofiber Dressing
7.3. Skin Substitutes
7.3.1. Xenograft
7.3.2. Allograft
7.3.3. Placenta/Amniotic Tissue
7.3.4. Bioengineered skin/synthetic Substitutes
7.4. Therapy Devices
7.4.1. Negative Pressure Wound Therapies (NPWT Devices)
7.4.1.1. Conventional Negative Pressure Wound Therapy (NPWT)
7.4.1.1.1. Pumps
7.4.1.1.2. Canisters
7.4.1.1.3. Dressing Kits
7.4.1.2. Single-Use Negative Pressure Wound Therapy (NPWT)
7.4.2. Hyperbaric Oxygen Therapy
7.4.3. Ultrasonic Mist and Electrical Stimulation Devices
7.5. Compression Bandage
7.5.1. Full Compression – 2 layers
7.5.2. Others
8. By Wound Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
8.1.2. Market Attractiveness Index, By Wound Type
8.2. Chronic Wounds
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.2.2.1. Pressure Ulcer (PU)
8.2.2.2. Venous Leg Ulcer (VLU)
8.2.2.3. Diabetic Foot Ulcer (DFU)
8.3. Acute Wounds
9. By Country
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
9.1.2. Market Attractiveness Index, By Country
9.2. Germany
9.2.1. Introduction
9.2.2. Key Country-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
9.3. U.K.
9.3.1. Introduction
9.3.2. Key Country-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
9.4. France
9.4.1. Introduction
9.4.2. Key Country-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
9.5. Italy
9.5.1. Introduction
9.5.2. Key Country-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
9.6. Spain
9.6.1. Introduction
9.6.2. Key Country-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
9.7. Rest of Europe
9.7.1. Introduction
9.7.2. Key Country-Specific Dynamics
9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. Company Profiles
11.1. 3M Company
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. B. Braun Melsungen AG
11.3. Integra Lifesciences
11.4. Cardinal Health Inc.
11.5. Molnlycke Health Care
11.6. Smith & Nephew
11.7. Coloplast AS
11.8. 3M Company
11.9. ConvaTec Group PLC
11.10. Paul Hartmann AG
11.11. Medtronic PLC
LIST NOT EXHAUSTIVE
12. DataM
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us